Literature DB >> 3415196

Validation of clinical diagnostic criteria for Alzheimer's disease.

J C Morris1, D W McKeel, K Fulling, R M Torack, L Berg.   

Abstract

Clinical investigations of Alzheimer's disease (AD) have been limited by diagnostic inaccuracy. We employed explicit clinical inclusion and exclusion criteria to identify subjects with senile dementia of the Alzheimer type (SDAT). In a consecutive series of 26 postmortem examinations from this sample, AD was histologically verified in all subjects and was the primary dementing illness. Seventeen of the 26 SDAT subjects had been diagnosed when only mildly demented. Two control subjects were examined neuropathologically; AD was absent in both. We conclude that research clinical diagnostic criteria for SDAT, even in its mild stage, are valid.

Entities:  

Mesh:

Year:  1988        PMID: 3415196     DOI: 10.1002/ana.410240105

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  73 in total

Review 1.  Seizures and epilepsy in Alzheimer's disease.

Authors:  Daniel Friedman; Lawrence S Honig; Nikolaos Scarmeas
Journal:  CNS Neurosci Ther       Date:  2011-06-07       Impact factor: 5.243

2.  The Cognitive Change in Women study (CCW): informant ratings of cognitive change but not self-ratings are associated with neuropsychological performance over 3 years.

Authors:  Rebecca Gavett; Julie E Dunn; Anne Stoddard; Brian Harty; Sandra Weintraub
Journal:  Alzheimer Dis Assoc Disord       Date:  2011 Oct-Dec       Impact factor: 2.703

3.  Idea density measured in late life predicts subsequent cognitive trajectories: implications for the measurement of cognitive reserve.

Authors:  Sarah Tomaszewski Farias; Vineeta Chand; Lisa Bonnici; Kathleen Baynes; Danielle Harvey; Dan Mungas; Christa Simon; Bruce Reed
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2012-02-22       Impact factor: 4.077

4.  The development of memory efficiency and value-directed remembering across the life span: a cross-sectional study of memory and selectivity.

Authors:  Alan D Castel; Kathryn L Humphreys; Steve S Lee; Adriana Galván; David A Balota; David P McCabe
Journal:  Dev Psychol       Date:  2011-09-26

5.  Effects of healthy aging and early stage dementia of the Alzheimer's type on components of response time distributions in three attention tasks.

Authors:  Chi-Shing Tse; David A Balota; Melvin J Yap; Janet M Duchek; David P McCabe
Journal:  Neuropsychology       Date:  2010-05       Impact factor: 3.295

6.  Predicting conversion to dementia of the Alzheimer's type in a healthy control sample: the power of errors in Stroop color naming.

Authors:  David A Balota; Chi-Shing Tse; Keith A Hutchison; Daniel H Spieler; Janet M Duchek; John C Morris
Journal:  Psychol Aging       Date:  2010-03

7.  Auditory confrontation naming in Alzheimer's disease.

Authors:  Jason Brandt; Arnold Bakker; David Aaron Maroof
Journal:  Clin Neuropsychol       Date:  2010-10-27       Impact factor: 3.535

8.  Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease.

Authors:  T Gómez-Isla; J L Price; D W McKeel; J C Morris; J H Growdon; B T Hyman
Journal:  J Neurosci       Date:  1996-07-15       Impact factor: 6.167

9.  Clinical and psychological characteristics of the initial cohort of the Dominantly Inherited Alzheimer Network (DIAN).

Authors:  Martha Storandt; David A Balota; Andrew J Aschenbrenner; John C Morris
Journal:  Neuropsychology       Date:  2013-11-11       Impact factor: 3.295

Review 10.  Use of genetic variation as biomarkers for Alzheimer's disease.

Authors:  Christiane Reitz; Richard Mayeux
Journal:  Ann N Y Acad Sci       Date:  2009-10       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.